PLASMA HOMOCYSTEINE LEVELS AND THEIR INDEPENDENT ASSOCIATION WITH CAROTID ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES

Thị Kim Châu Đoàn 1, , Thị Bích Trâm Võ 2, Đức Lộc Ngô 1, Ngọc Mai Trương 3
1 Can Tho University of Medicine and Pharmacy
2 Hoan My Cuu Long Hospital
3 Can Tho University of Medicine and Pharmacy Hospital

Main Article Content

Abstract

Background: Homocysteine (Hcy) is recognized as an independent risk factor for atherosclerosis; however, data regarding this association among patients with type 2 diabetes (T2D) in Vietnam remain limited. Objectives: This study aimed to investigate plasma Hcy levels and analyze their independent association with carotid intima-media thickness (cIMT) and the presence of carotid plaques in T2D patients. Materials and methods: A cross-sectional study was conducted on 134 T2D patients at Can Tho University of Medicine and Pharmacy Hospital from August 2022 to April 2024. Participants were stratified by Hcy quartiles to evaluate clinical characteristics and carotid ultrasound parameters. Data were analyzed using R software (version 4.5.0), utilizing statistical tests and multivariable linear regression models. Results: Elevated Hcy levels were significantly associated with smoking and reduced estimated glomerular filtration rate (p < 0.001). Mean cIMT and the prevalence of carotid plaques were significantly higher in the upper Hcy quartiles (p < 0.05). Multivariable regression analysis confirmed Hcy as an independent factor associated with increased cIMT (Beta = 0.19, p = 0.007), exhibiting a linear correlation (p = 0.014). Conclusion: Elevated plasma homocysteine levels are associated with impaired renal function and serve as an independent prognostic factor for carotid atherosclerotic damage in patients with type 2 diabetes.

Article Details

References

1. Nguyễn Bảo Hiền, Đoàn Văn Đệ, Nguyễn Văn Đàm (2022), Khảo sát nồng độ, tỷ lệ biến đổi Homocystein huyết tương ở bệnh nhân đái tháo đường típ 2, Tạp chí Y học Việt Nam, 516 (1), pp. doi:http://doi.org/10.51298/vmj.v516i1.2941.
2. Nguyễn Thị Bích Chi, Hồ Anh Bình (2025), Nghiên cứu nồng độ homocystein máu ở bệnh nhân đái tháo đường týp 2 có tổn thương động mạch vành, Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế, (67), pp. 34-46. doi:http://doi.org/10.38103/jcmhch.2021.67.6.
3. Trần Việt Cường, Đỗ Doãn Lợi (2025), Nồng độ Homocystein ở người bệnh đái tháo đường type 2 có hội chứng động mạch vành mạn, Tạp chí Tim mạch học Việt Nam, (114), pp. doi:http://doi.org/10.58354/jvc.114.2025.906.
4. S. S. Habib, T. Al-Khlaiwi, A. Almushawah, A. Alsomali et al. (2023), Homocysteine as a predictor and prognostic marker of atherosclerotic cardiovascular disease: a systematic review and meta-analysis, Eur Rev Med Pharmacol Sci, 27 (18), pp. 8598-8608. doi:http://doi.org/10.26355/eurrev_202309_33784.
5. Z. Huang, Q. Zhang, J. Zhang, R. Zhang et al. (2025), Association of plasma homocysteine with cardiovascular disease in American adults: a study based on the national health and nutrition examination survey database, Front Cardiovasc Med, 12 pp. 1528540. doi:http://doi.org/10.3389/fcvm.2025.1528540.
6. S. K. Singh, R. K. Jha, R. S. Ambad,R. K. Jha (2025), Systematic Review and Meta-Analysis to Explore the Relationship of Increased Homocysteine, Lipid Levels and Lipid Ratios In-Cad, J Pharm Bioallied Sci, 17 (Suppl 1), pp. S121-s123. doi:http://doi.org/10.4103/jpbs.jpbs_1961_24.
7. B. Wang, X. Mo, Z. Wu,X. Guan (2022), Systematic review and meta-analysis of the correlation between plasma homocysteine levels and coronary heart disease, J Thorac Dis, 14 (3), pp. 646-653. doi:http://doi.org/10.21037/jtd-22-78.
8. D. Yuan, J. Chu, H. Lin, G. Zhu et al. (2022), Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis, Front Cardiovasc Med, 9 pp. 1109445. doi:http://doi.org/10.3389/fcvm.2022.1109445.